The Global Ventricular Tachycardia Market is estimated to be valued at USD 15.52 Bn in 2025 and is expected to reach USD 22.28 Bn by 2032, reflecting a compound annual growth rate (CAGR) of 5.3% from ...

If you've been diagnosed with high blood pressure, you're not alone-and you're probably wondering what you can do about it.

Review clinical classifications, diagnostic procedures, and management strategies for cardiomyopathy and heart failure in this comprehensive overview.

Nearly half of U.S. adults struggle with high blood pressure-no wonder there's a seeming sea of medications claiming to lower ...

Latigo Biotherapeutics Inc. has synthesized sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers. They are reported to be useful for the treatment of pain, cough and pruritus.

Praxis Precision Medicines, Inc. uses a genetics-driven approach to develop potential best-in-class drugs for patients with central nervous system (CNS) disorders that are characterized by faulty ...

Researchers are uncovering how disrupted glutamatergic synapses drive diverse forms of intellectual disability, revealing new ...

The funding will support a GLP-1 pill Corxel licensed from China-based Vincentage in 2024 and that the company believes to be ...

As with the many other “most-favored-nation” deals between the White House and large pharmas, the agreement is short on ...

Even within the healthy range, small differences in blood sodium were associated with measurable changes in brain excitability, offering new insight into how subtle physiology may shape neural ...